In a report released today, Jason Bednar from Piper Sandler maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report), with a price target of $35.00. The company’s shares closed last Friday at $33.91.
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Cooper Co, and Envista Holdings. According to TipRanks, Bednar has an average return of -3.8% and a 42.20% success rate on recommended stocks.
DENTSPLY SIRONA has an analyst consensus of Moderate Buy, with a price target consensus of $37.86.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $42.74 and a one-year low of $26.17. Currently, DENTSPLY SIRONA has an average volume of 3.17M.
Based on the recent corporate insider activity of 108 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of XRAY in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
DENTSPLY SIRONA (XRAY) Company Description:
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.
Read More on XRAY:
- Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th
- Dentsply Sirona price target raised to $35 from $32 at Stifel
- Dentsply Sirona price target raised to $35 from $31 at Piper Sandler
- Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results
- Dentsply Sirona sees double-digit adjusted EPS growth in 2024
